Abstract:Cellular growth, function, and protection require proper iron management, and ferritin plays a crucial role as the major iron sequestration and storage protein. Ferritin is a 24 subunit spherical shell protein composed of both light (FTL) and heavy chain (FTH1) subunits, possessing complimentary iron-handling functions and forming three-fold and four-fold pores. Iron uptake through the three-fold pores is well-defined, but the unloading process somewhat less and generally focuses on lysosomal ferritin degradation although it may have an additional, energetically efficient pore mechanism. Hereditary Ferritinopathy (HF) or neuroferritinopathy is an autosomal dominant neurodegenerative disease caused by mutations in the FTL C-terminal sequence, which in turn cause disorder and unraveling at the four-fold pores allowing iron leakage and enhanced formation of toxic, improperly coordinated iron (ICI). Histopathologically, HF is characterized by iron deposition and formation of ferritin inclusion bodies (IBs) as the cells overexpress ferritin in an attempt to address iron accumulation while lacking the ability to clear ferritin and its aggregates. Overexpression and IB formation tax cells materially and energetically, i.e., their synthesis and disposal systems, and may hinder cellular transport and other spatially dependent functions. ICI causes cellular damage to proteins and lipids through reactive oxygen species (ROS) formation because of high levels of brain oxygen, reductants and metabolism, taxing cellular repair. Iron can cause protein aggregation both indirectly by ROS-induced protein modification and destabilization, and directly as with mutant ferritin through C-terminal bridging. Iron release and ferritin degradation are also linked to cellular misfunction through ferritinophagy, which can release sufficient iron to initiate the unique programmed cell death process ferroptosis causing ROS formation and lipid peroxidation. But IB buildup suggests suppressed ferritinophagy, with elevated iron from four-fold pore leakage together with ROS damage and stress leading to a long-term ferroptotic-like state in HF. Several of these processes have parallels in cell line and mouse models. This review addresses the roles of ferritin structure and function within the above-mentioned framework, as they relate to HF and associated disorders characterized by abnormal iron accumulation, protein aggregation, oxidative damage, and the resulting contributions to cumulative cellular stress and death.

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

WDR45 Mutation Impairs the Autophagic Degradation of Transferrin Receptor and Promotes Ferroptosis

Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration

Ferritinophagy: Molecular mechanisms and role in disease

Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases

Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases: TANG et al.

The Critical Role of Ferritinophagy in Human Disease

Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis

Ferritinophagy in the etiopathogenic mechanism of related diseases

Ferroptosis is an autophagic cell death process

Ferritinophagy and Ferroptosis in the Management of Metabolic Diseases

Autophagy-Dependent Ferroptosis in Cancer

Ferritinophagy: A novel insight into the double-edged sword in ferritinophagy-ferroptosis axis and human diseases

Methods for Monitoring NCOA4-Mediated Ferritinophagy

Ferritinophagy: research advance and clinical significance in cancers

International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis

Revealing the Ferroptotic Phenotype of Medulloblastoma

Cardiac glycosides restore autophagy flux in an iPSC-derived neuronal model of WDR45 deficiency

WDR45 Mutation Dysregulates Iron Homeostasis by Promoting the Chaperone-Mediated Autophagic Degradation of Ferritin Heavy Chain in an ER Stress/p38 Dependent Mechanism.

L-serine restored lysosomal failure in cells derived from patients with BPAN reducing iron accumulation with eliminating lipofuscin

Considerations for Using Neuroblastoma Cell Lines to Examine the Roles of Iron and Ferroptosis in Neurodegeneration